July 2026 FDA Recall Dorzolamide Hydrochloride And Timolol Maleate Ophthalmic Solution by Micro Labs Usa Inc
D-0730-2026 - Defective Container

This Class II drug recall was voluntarily initiated by Micro Labs Usa Inc on July 22, 2026 for the product Dorzolamide Hydrochloride And Timolol Maleate Ophthalmic Solution. The FDA reported the reason for recall as defective container. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0730-2026

Reason for Recall
Defective Container: Firm received multiple complaints of broken cap spikes and undeliverable drops.
Initiated
07-22-2026
Reported
08-05-2026
Quantity
N/A

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the USA.
Dorzolamide HCl and Timolol Maleate Ophthalmic Solution, USP, 2%/0.5%, 10mL - bottle, Rx only, Manufactured by: Micro Labs Limited, India, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873. NDC 42571-147-26.

Batch or Lot Expiration Information

Lot# DLHU0031, Exp Date: 06/30/2027.